1. A systematic review of multimodal prehabilitation in breast cancer

   • Kellie Toohey
   • Maddison Hunter
   • Catherine Paterson

   Review Open access 21 October 2022 Pages: 1 - 37

   

2. Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance

   • Shelley Potter
   • Katherine Fairhurst
   • Stuart A. McIntosh

   Review Open access 01 November 2022 Pages: 39 - 49

   

3. Emerging strategies: PARP inhibitors in combination with immune checkpoint blockade in BRCA1 and BRCA2 mutation-associated and triple-negative breast cancer

   • Tanya Gupta
   • Shaveta Vinayak
   • Melinda Telli

   Review 01 November 2022 Pages: 51 - 56

   

4. EGFR as a potent CAR T target in triple negative breast cancer brain metastases

   • Siddharth Subham
   • John D. Jeppson
   • David Akhavan

   Preclinical study 01 November 2022 Pages: 57 - 69

   

5. Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis

   • Cao Lu
   • Yang Yang
   • Zhang peisen

   Preclinical study 05 November 2022 Pages: 71 - 82

   

6. Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective

   • Alina A. Ghazaleh
   • Tristan M. Handschin
   • Katrin Seidenstuecker

   Clinical trial Open access 26 October 2022 Pages: 83 - 92

   

7. Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial

   • Xiao-Feng Xie
   • Qiu-Yi Zhang
   • Cai-Wen Du

   Clinical trial Open access 30 October 2022 Pages: 93 - 101

   

8. Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer

   • Giovanni Corso
   • Antonia Girardi
   • Bernardo Bonanni

   Clinical trial 04 November 2022 Pages: 103 - 112

   

9. Investigating the role of core needle biopsy in evaluating tumor-stroma ratio (TSR) of invasive breast cancer: a retrospective study

   • Minh-Khang Le
   • Toru Odate
   • Tetsuo Kondo

   Clinical trial 06 November 2022 Pages: 113 - 121

   

10. Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis

    • Anouk H. Eijkelboom
    • Linda de Munck
    • Sabine Siesling

    Epidemiology Open access 31 October 2022 Pages: 123 - 135

    

11. Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study

    • Laura A. Huppert
    • Zak Walker
    • A. Jo Chien

    Epidemiology 02 November 2022 Pages: 137 - 148

    

12. A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia

    • Mark Powell
    • Sophia Fuller
    • Christopher Benz

    Epidemiology Open access 04 November 2022 Pages: 149 - 159

    

13. Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study

    • Anouk H. Eijkelboom
    • Linda de Munck
    • The COVID and Cancer Care-NL Consortium

    Epidemiology Open access 05 November 2022 Pages: 161 - 175

    

14. Implications of missing data on reported breast cancer mortality

    • Jennifer K. Plichta
    • Christel N. Rushing
    • Rachel A. Greenup

    Epidemiology 05 November 2022 Pages: 177 - 187

    

15. Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population

    • Ruixian Chen
    • Yana Qi
    • Jie Chen

    Epidemiology Open access 08 November 2022 Pages: 189 - 200

    

16. Impact of a pre-existing diagnosis of mental illness on stage of breast cancer diagnosis among older women

    • Manami Bhattacharya
    • Helen Parsons
    • Donna McAlpine

    Epidemiology 09 November 2022 Pages: 201 - 210

    

17. Development of a key performance indicator for breast cancer in Queensland, Australia

    • Euan T. Walpole
    • Philippa H. Youl
    • Shoni Philpot

    Epidemiology Open access 09 November 2022 Pages: 211 - 221

    

18. Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer

    • Joan M. Neuner
    • Nicole Fergestrom
    • Aaron N. Winn

    Epidemiology 10 November 2022 Pages: 223 - 233

    

19. Superficial and functional imaging of the tricipital lymphatic pathway: a modern reintroduction

    • Rosie Friedman
    • Valeria P. Bustos
    • Dhruv Singhal

    Original Laboratory Investigation 03 November 2022 Pages: 235 - 242

    

20. Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary

    • Fei-Lin Qu
    • Jun-Jie Li
    • Zhi-Ming Shao

    Letter to the Editor 30 October 2022 Pages: 243 - 244